46 min listen
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
ratings:
Length:
24 minutes
Released:
Mar 28, 2024
Format:
Podcast episode
Description
Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology and Neuroinflammation. Disclosures can be found at Neurology.org.
Released:
Mar 28, 2024
Format:
Podcast episode
Titles in the series (100)
March 11 2008 Issue: The varicella zoster virus vasculopathies: Clinical, CSF, imaging and virological features by Neurology® Podcast